Global Hypercalcemia Treatment Market 2017-2021

Publisher Name :
Date: 19-Apr-2017
No. of pages: 70
Inquire Before Buying

ABSTRACT

About Hypercalcemia Treatment

Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain. Hypercalcemia refers to the condition where too much calcium enters the extracellular fluid or when there is insufficient calcium excretion from the kidneys. The cases of hypercalcemia are mainly caused by malignancy or hyperparathyroidism. Hypercalcemia is an outcome of overactive parathyroid glands. These four tiny glands are located near thyroid gland and each of them are about the size of a rice grain.

The analysts forecast global hypercalcemia treatment market to grow at a CAGR of 5.44% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global hypercalcemia treatment market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Hypercalcemia Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AbbVie

Amgen

Merck

Novartis

OPKO Health

Other prominent vendors

DiaSorin

Rockwell Medical

Kyowa Hakko Kirin

Fujirebio

Market driver

Expanding label indications.

For a full, detailed list, view our report

Market challenge

Severe threat of damage to nervous system.

For a full, detailed list, view our report

Market trend

Growing focus on emerging economies.

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Global Hypercalcemia Treatment Market 2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Key market highlights
PART 05: An overview of Hypercalcemia
PART 06: Pipeline Analysis
PART 07: Market landscape
Market overview
Five forces analysis
PART 08: Market segmentation by product type
Bisphosphonates
Glucocorticoids
Calcimimetic agents
Others
PART 09: Market segmentation by geography
Hypercalcemia treatment market in Americas
Hypercalcemia treatment market in EMEA
Hypercalcemia treatment market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
Market drivers
Impact of drivers on key customer segments
Market challenges
Impact of challenges on key customer segments
PART 12: Market trends
Combination therapy
Increase in outsourcing
Growing focus on emerging economies
PART 13: Vendor landscape
Competitive scenario
PART 14: Key vendor analysis
AbbVie
Amgen
Merck
Novartis
OPKO Health
Other prominent vendors
PART 15: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Body parts affected by high calcium
Exhibit 02: Pipeline landscape
Exhibit 03: Global hypercalcemia treatment market snapshot
Exhibit 04: Global hypercalcemia treatment market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global hypercalcemia treatment market
Exhibit 06: Five forces analysis
Exhibit 07: Market segmentation by product type 2016
Exhibit 08: Bisphosphonates segment 2016-2021 ($ millions)
Exhibit 09: Glucocorticoids segment 2016-2021 ($ millions)
Exhibit 10: Calcimimetic agents segment 2016-2021 ($ millions)
Exhibit 11: Global hypercalcemia treatment market by geography 2016 and 2021
Exhibit 12: Global hypercalcemia treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Hypercalcemia treatment market in Americas ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Hypercalcemia treatment market in EMEA ($ millions)
Exhibit 17: Market scenario in APAC
Exhibit 18: Hypercalcemia treatment market in APAC ($ millions)
Exhibit 19: Key approvals
Exhibit 20: Key factors driving the market growth
Exhibit 21: Impact of drivers
Exhibit 22: Impact of serum calcium concentration
Exhibit 23: Impact of challenges
Exhibit 24: Competitive structure analysis of global hypercalcemia treatment market 2016
Exhibit 25: Competitive analysis of global hypercalcemia market
Exhibit 26: AbbVie: Key highlights
Exhibit 27: AbbVie: Strength assessment
Exhibit 28: AbbVie: Strategy assessment
Exhibit 29: AbbVie: Opportunity assessment
Exhibit 30: Amgen: Key highlights
Exhibit 31: Amgen: Strength assessment
Exhibit 32: Amgen: Strategy assessment
Exhibit 33: Amgen: Opportunity assessment
Exhibit 34: Merck: Key highlights
Exhibit 35: Merck: Strength assessment
Exhibit 36: Merck: Strategy assessment
Exhibit 37: Merck: Opportunity assessment
Exhibit 38: Novartis: Strength assessment
Exhibit 39: Novartis: Strategy assessment
Exhibit 40: Novartis: Opportunity assessment
Exhibit 41: OPKO Health: Key highlights
Exhibit 42: OPKO Health: Strength assessment
Exhibit 43: OPKO Health: Strategy assessment
Exhibit 44: OPKO Health: Opportunity assessment
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies [...]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new [...]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating [...]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Friedreich Ataxia - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 85
    Friedreich Ataxia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Friedreich Ataxia - Pipeline Review, H1 2017, provides an overview of the Friedreich Ataxia (Central Nervous System) pipeline landscape. Friedreich's ataxia (FA) is a neuromuscular disease that mainly affects the nervous system and the heart. FA is a hereditary disease, caused by a defective gene that can be passed dow......
  • Liver Fibrosis - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 200
    Liver Fibrosis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Fibrosis - Pipeline Review, H1 2017, provides an overview of the Liver Fibrosis (Gastrointestinal) pipeline landscape. Liver fibrosis is a scarring process which results in inflammation and liver cell death. Symptoms include abdominal pain, easy bruising, lack of appetite, nausea, tenderness and enlargement of the l......
  • Fragile X Syndrome - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 108
    Fragile X Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Pipeline Review, H1 2017, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, re......
  • Global Hypertrophic Cardiomyopathy Therapeutics Market 2017-2021
    Published: 05-Apr-2017        Price: US 3500 Onwards        Pages: 70
    HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers to diseases related to heart muscles. Therefore, HCM is defined as a condition, which is characterized by abnormal thickening of heart muscles, which makes pumping of blood from the heart to variou......
  • Sarcopenia - Epidemiology Forecast To 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's "Sarcopenia - Epidemiology Forecast To 2023" Report provides an overview of the epidemiology trends of Sarcopenia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes historical and forecasted epidemiological data for the prevalent cases of Sarcopenia from 2013-2023. Sarcopenia is the progressive loss of skeletal muscle that comes with aging. Sarcopenia is multifactorial in cause. Most people begin to lose modest amounts of muscle mass after......
  • Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017
    Published: 01-Apr-2017        Price: US 2450 Onwards        Pages: 207
    DelveInsight's report, "Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017", emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development. The report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell based therapies and drugs that augment (enhance or activate) the NK cells. The report provides in-depth analysis on t......
  • Sarcopenia - Market Insights, Epidemiology and Market Forecast -2023-7 MM
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 51
    DelveInsight's "Sarcopenia - Market Insights, Epidemiology and Market Forecast-2023-7 MM" Report provides an overview of the disease and global market size of the Sarcopenia for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Sarcopenia from 2013-2023. Sarcopenia is the progressive loss of skeletal muscle that comes with aging. Sarcopenia is multifactorial in cause. Most peopl......
  • Acromegaly and Gigantism- Epidemiology Forecast To 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's"Acromegaly and Gigantism- Epidemiology Forecast to 2023" Report provides an overview of the epidemiology trends of Acromegaly in seven major markets (US, France, Germany, Italy, Spain, UK and Japan) and Gigantism in six major markets (US, United Kingdom, France, Germany, Italy and Spain). It includes 10 years epidemiology historical and forecasted data of prevalent cases of Acromegaly and Gigantism by age, sex and sub populations. The Report also discusses the prevailing risk fact......
  • Achondroplasia - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 35
    Achondroplasia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H1 2017, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline landscape. Achondroplasia is a bone growth disorder that causes disproportionate dwarfism. This is caused by mutations in the FGFR3 gene. Symptoms include decreased muscle tone, apnea, hydrocephalus, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs